{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:04:06Z","timestamp":1789427046777,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":118,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship"],"award-info":[{"award-number":["Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0291-2019"],"award-info":[{"award-number":["PI-0291-2019"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020230","name":"Consejer\u00eda de Transformaci\u00f3n Econ\u00f3mica, Industria, Conocimiento y Universidades","doi-asserted-by":"publisher","award":["P20_01314"],"award-info":[{"award-number":["P20_01314"]}],"id":[{"id":"10.13039\/100020230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Proyectos Grupos PAIDI de Investigaci\u00f3n - Universidad de M\u00e1laga","award":["CTS650"],"award-info":[{"award-number":["CTS650"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-026-00970-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:32:06Z","timestamp":1779305526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Jes\u00fas","family":"Velasco-Suelto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Quir\u00f3s-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Godoy-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Alba-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Emilia","family":"Dom\u00ednguez-Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Jim\u00e9nez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Peralta-Linero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Bellagarza-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Troyano-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garrido-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Hierro-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Garrido-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Lavado-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-2603","authenticated-orcid":false,"given":"Emilio","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-9432","authenticated-orcid":false,"given":"I\u00f1aki","family":"Comino-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"970_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"970_CR2","doi-asserted-by":"publisher","unstructured":"Howlader, N. et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J. Natl. Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju055 (2014).","DOI":"10.1093\/jnci\/dju055"},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836\u20131846 (2017).","journal-title":"N. Engl. J. Med."},{"key":"970_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jnci\/djab202","volume":"114","author":"RN Pedersen","year":"2022","unstructured":"Pedersen, R. N. et al. The incidence of breast cancer recurrence 10-32 years after primary diagnosis. J. Natl. Cancer Inst. 114, 391\u2013399 (2022).","journal-title":"J. Natl. Cancer Inst."},{"key":"970_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","volume":"21","author":"WJ Gradishar","year":"2023","unstructured":"Gradishar, W. J. et al. NCCN Guidelines(R) Insights: Breast Cancer, Version 4.2023. J. Natl. Compr. Cancer Netw. 21, 594\u2013608 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11033-024-10198-0","volume":"52","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. & Yuan, X. Minimal residue disease detection in early-stage breast cancer: a review. Mol. Biol. Rep. 52, 106 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"970_CR7","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-24-3472","volume":"31","author":"MJ Elliott","year":"2025","unstructured":"Elliott, M. J. et al. Ultrasensitive detection and monitoring of circulating tumor DNA using structural variants in early-stage breast cancer. Clin. Cancer Res. 31, 1520\u20131532 (2025).","journal-title":"Clin. Cancer Res."},{"key":"970_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00456","volume":"8","author":"JA Shaw","year":"2024","unstructured":"Shaw, J. A. et al. Serial postoperative circulating tumor DNA assessment has strong prognostic value during long-term follow-up in patients with breast cancer. JCO Precis. Oncol. 8, e2300456 (2024).","journal-title":"JCO Precis. Oncol."},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1200\/JCO.22.00908","volume":"40","author":"M Lipsyc-Sharf","year":"2022","unstructured":"Lipsyc-Sharf, M. et al. Circulating tumor DNA and late recurrence in high-risk hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. J. Clin. Oncol. 40, 2408\u20132419 (2022).","journal-title":"J. Clin. Oncol."},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1078-0432.CCR-19-3005","volume":"26","author":"HA Parsons","year":"2020","unstructured":"Parsons, H. A. et al. Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer. Clin. Cancer Res. 26, 2556\u20132564 (2020).","journal-title":"Clin. Cancer Res."},{"key":"970_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jamaoncol.2019.1838","volume":"5","author":"I Garcia-Murillas","year":"2019","unstructured":"Garcia-Murillas, I. et al. Assessment of molecular relapse detection in early-stage breast cancer. JAMA Oncol. 5, 1473\u20131478 (2019).","journal-title":"JAMA Oncol."},{"key":"970_CR12","doi-asserted-by":"crossref","unstructured":"Hunter, N. B. et al. The pathologic response evaluation and detection in circulating tumor-DNA study: ultrasensitive circulating tumor-DNA assessment of breast cancer minimal residual disease. J. Clin. Oncol. 44, 1283\u20131295 (2026).","DOI":"10.1200\/JCO-25-02934"},{"key":"970_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103100","volume":"62","author":"A Alba-Bernal","year":"2020","unstructured":"Alba-Bernal, A. et al. Challenges and achievements of liquid biopsy technologies employed in early breast cancer. EBioMedicine 62, 103100 (2020).","journal-title":"EBioMedicine"},{"key":"970_CR14","doi-asserted-by":"publisher","unstructured":"Rack, B. et al. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J. Natl. Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju066 (2014).","DOI":"10.1093\/jnci\/dju066"},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-15-1603","volume":"22","author":"WJ Janni","year":"2016","unstructured":"Janni, W. J. et al. Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer. Clin. Cancer Res. 22, 2583\u20132593 (2016).","journal-title":"Clin. Cancer Res."},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/djy018","volume":"110","author":"FC Bidard","year":"2018","unstructured":"Bidard, F. C. et al. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis. J. Natl. Cancer Inst. 110, 560\u2013567 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"970_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.15252\/emmm.201404913","volume":"7","author":"E Olsson","year":"2015","unstructured":"Olsson, E. et al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Med. 7, 1034\u20131047 (2015).","journal-title":"EMBO Mol. Med."},{"key":"970_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00319-4","volume":"7","author":"A Bortolini Silveira","year":"2021","unstructured":"Bortolini Silveira, A. et al. Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. npj Breast Cancer 7, 115 (2021).","journal-title":"npj Breast Cancer"},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1200\/PO.20.00345","volume":"5","author":"L Gerratana","year":"2021","unstructured":"Gerratana, L. et al. Longitudinal dynamics of circulating tumor cells and circulating tumor DNA for treatment monitoring in metastatic breast cancer. JCO Precis. Oncol. 5, 943\u2013952 (2021).","journal-title":"JCO Precis. Oncol."},{"key":"970_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00642-6","volume":"10","author":"A Alba-Bernal","year":"2024","unstructured":"Alba-Bernal, A. et al. Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients. npj Breast Cancer 10, 36 (2024).","journal-title":"npj Breast Cancer"},{"key":"970_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103687","volume":"9","author":"R Cutts","year":"2024","unstructured":"Cutts, R. et al. Association of post-operative ctDNA detection with outcomes of patients with early breast cancers. ESMO Open 9, 103687 (2024).","journal-title":"ESMO Open"},{"key":"970_CR22","doi-asserted-by":"publisher","unstructured":"Elliott, M. J. et al. Abstract PS06-08: longitudinal neoadjuvant and post-operative evaluation of circulating tumor DNA in early breast cancer using a tumor-informed assay: updated analysis of the TRACER Cohort. Cancer Res. 84, https:\/\/doi.org\/10.1158\/1538-7445.SABCS23-PS06-08 (2024).","DOI":"10.1158\/1538-7445.SABCS23-PS06-08"},{"key":"970_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10549-024-07508-2","volume":"209","author":"I Garcia-Murillas","year":"2025","unstructured":"Garcia-Murillas, I. et al. Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer. Breast Cancer Res. Treat. 209, 493\u2013502 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"970_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.annonc.2020.11.007","volume":"32","author":"MJM Magbanua","year":"2021","unstructured":"Magbanua, M. J. M. et al. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival. Ann. Oncol. 32, 229\u2013239 (2021).","journal-title":"Ann. Oncol."},{"key":"970_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.annonc.2025.01.021","volume":"36","author":"I Garcia-Murillas","year":"2025","unstructured":"Garcia-Murillas, I. et al. Whole genome sequencing-powered ctDNA sequencing for breast cancer detection. Ann. Oncol. 36, 673\u2013681 (2025).","journal-title":"Ann. Oncol."},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/jamaoncol.2020.2295","volume":"6","author":"M Radovich","year":"2020","unstructured":"Radovich, M. et al. Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer: preplanned secondary analysis of the BRE12-158 randomized clinical trial. JAMA Oncol. 6, 1410\u20131415 (2020).","journal-title":"JAMA Oncol."},{"key":"970_CR27","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","volume":"25","author":"RC Coombes","year":"2019","unstructured":"Coombes, R. C. et al. Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence. Clin. Cancer Res. 25, 4255\u20134263 (2019).","journal-title":"Clin. Cancer Res."},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff, A. C. et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 25, 118\u2013145 (2007).","journal-title":"J. Clin. Oncol."},{"key":"970_CR29","doi-asserted-by":"publisher","first-page":"e0231854","DOI":"10.1371\/journal.pone.0231854","volume":"15","author":"CK Raymond","year":"2020","unstructured":"Raymond, C. K., Raymond, F. C. & Hill, K. UltraPrep is a scalable, cost-effective, bead-based method for purifying cell-free DNA. PLoS ONE 15, e0231854 (2020).","journal-title":"PLoS ONE"},{"key":"970_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman, R. L. et al. Toward a shared vision for cancer genomic data. N. Engl. J. Med. 375, 1109\u20131112 (2016).","journal-title":"N. Engl. J. Med."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00970-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00970-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00970-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:22:36Z","timestamp":1789424556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00970-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00970-9","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"121"}}